DISABILITY ACTIVISTS PROTEST “ASHLEY TREATMENT”
Stunting the growth of a severely physically and intellectually disabled American girl has been denounced by disability activists. As reported in last week’s BioEdge, doctors in Seattle limited the height of six-year-old Ashley, and removed her breast buds, her uterus and her appendix. Their aim was to help the girl’s parents cope with caring for her.
Media coverage has provoked a storm of controversy. Complaints have been filed with the federal Office for Human Research Protections, although the agency says that it has no authority to investigate it. Steven Taylor, of Syracuse University, said that “it is unethical and unacceptable to perform intrusive and invasive medical procedures on a person or child with a disability simply to make the person easier to care for.”
The fact that a hospital ethics committee had reviewed the case did not impress the Chicago group Not Dead Yet. It called for a total ban on the “Ashley Treatment”. “Ethics committees are not a substitute for the constitutionally-guaranteed right of due process,” it declared in a press release. “In fact, they often act an an end-run around those protections.”
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...